This protocol addresses the management of suspected or confirmed meningococcal disease in patients who have a severe allergy to beta-lactam antibiotics. When standard beta-lactam agents cannot be used safely, an alternative treatment path is required.
Beta-lactam allergy encompasses reactions to penicillin, amoxicillin, and cephalosporins. When this allergic reaction is severe, standard first-line agents are contraindicated and an alternative antibiotic approach is needed.
In this setting, a specific antibiotic class is considered as a substitute for standard beta-lactam therapy — one that is not structurally related to penicillins or cephalosporins. Specialist input from an infection specialist is recommended as part of this pathway.
However, if the allergic reaction is severe, an alternative will be needed.
The committee discussed that chloramphenicol is commonly used in the case of severe beta-lactam (penicillin, amoxicillin, or cephalosporin) allergy.
Based on clinical knowledge and experience, the committee recommended that advice from an infection specialist (a microbiologist or infectious diseases specialist) should be sought and chloramphenicol should be considered for the antibiotic treatment of meningococcal disease in people with severe antibiotic allergy.
View source ↗